Pooled data analysis of efficacy and safety from Phase 2b and Phase 3 data sets in patients with early-stage Parkinson’s ...
SOUTH SAN FRANCISCO, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: DNLI) today announced initiation of dosing in a global Phase 2a clinical study, BEACON, of the investigational drug ...
A research team led by Professor Cho Il-joo of the convergence medicine class at Korea University School of Medicine ...
Medtronic Percept neurostimulators send electrical signals through thin wires to specific brain regions affected by ...
A Parkinson’s patient died after a 52-hour A&E wait meant he did not receive vital medication, an investigation has found.
A deadly horse disease is likely to be caused by a nerve poison growing in grassy fields, scientists believe ...
Although there is no cure, there are ways to relieve the tremors, stiffness, depression, anxiety, and memory problems caused ...
In the not to distant future, those arriving at Yale New Haven Hospital’s emergency room with stroke symptoms will be treated ...
New therapies that are less intrusive but more lasting than current interventions promise to arrest and even reverse neurodegeneration.
Pereira FC et al. The Parkinson’s disease drug entacapone disrupts gut microbiome homoeostasis via iron sequestration. Nat ...
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...